Ethyl 6-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate hydrochloride, 95.0%, 10g

(S)-2-(4-Methylcyclohexylidene)acetonitrile, 1g

5-Bromo-5'-phenyl-3'H-spiro[indoline-3,2'-[1,3,4]thiadiazol]-2-one, 98.00%, 250mg

2-(8-Chloronaphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 1g

(1R,2S)-rel-2-Phenylcyclopropanecarboxylic acid, 95.0%, 1g

1-N-Alloc-4-piperidone, 96.0%, 1g

1-(2-METHANESULFONYLOXYETHYL)-2-CHLOROBENZENE, 95.0%, 1g

2-Methyl-6-phenylpyridine, 95.0%, 5g

4-cyclopropyl-1-(3,4-dimethylphenyl)-1,6-dihydro-7H-pyrazolo[3,4-d]pyridazin-7-one, 95.0%, 500mg

Carbonate de manganèse(II), min 44% Mn, pa, 250 g, emballage plastique.

2,4-Bis(trifluoromethyl)-DL-phenylalanine, 1g

(4-Fluoro-2-(trifluoromethyl)phenyl)hydrazine hydrochloride, 95.0%, 5g

2-Amino-5,6-dimethylbenzothiazole>98.0%(HPLC)(T)5g